News & Events

Events

International SBCC Summit 2022

12/05/2022 - 12/09/2022

Marrakesh, Morocco

Behavioral interventions like physical distancing, mask-wearing and vaccine uptake around COVID-19 has brought increased public and policy attention to not only the role of social and behavior change (SBC) in saving lives and improving livelihoods, but also to what works in introducing new attitudes and practices in response to urgent crises. Throughout the 2022 Summit … Continued

Register

Special Event: Immunisation on the Road to Primary Health Care (PHC) and Universal Health Coverage (UHC)

12/12/2022

Virtual

WHEN: Monday, December 12, 2022 9:00 AM EST WHAT: Immunisation is a critical component of primary health care (PHC) and offers a clear entry point for multisectoral efforts to strengthen PHC and UHC. During this Special Event, the IA2030 Working Group on Strategic Priority 1 (SP1, Immunisation Programmes for Primary Health Care and Universal Health … Continued

Register

See All

News

Results 181 - 190 of 188

Are Tough Times Ahead for Countries Graduating from Foreign Aid?

During the next few years, over a dozen middle-income countries are likely to transition away from multilateral concessional assistance—that is, grants and loans that offer flexible or lenient terms for repayment—including support from International Development Association (IDA) and Gavi, the Vaccine Alliance. There are good reasons to worry these countries, including Nigeria and Pakistan, will … Continued

TVEE Publishes Open Source Health Economics Courses on OpenCourseWare

The Teaching Vaccine Economics Everywhere (TVEE) project is pleased to announce that three modules from its vaccine economics curriculum are now available to the public for free on the JHSPH OpenCourseWare (OCW). The modules published are Health Economics for Vaccines, Costing in Vaccine Planning and Programming, and Economic Evaluation and are available here. Anybody can … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

Armenia, Indonesia, Timor-Leste

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

New Rotavirus Vaccine Prequalified by WHO

Bharat Biotech announced that ROTAVAC® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Continued

LNCT Welcomes Curatio

The Curatio International Foundation (CIF) has joined the Learning Network for Countries in Transition as a regional partner based in Tbilisi, Georgia. Curatio brings a thorough understanding of the financial and programmatic aspects of immunization programs, expertise in health systems, financing and policy, and extensive experience on transition and sustainability of Gavi supported programs. Curatio will work … Continued

New Guide Helps Countries Assess Immunization Financing Options

Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable … Continued

Return on Investment from Immunization

Sachiko Ozawa, Samantha Clark, Allison Portnoy, Simrun Grewal, Logan Brenzel, and Damian G. Walker An important research article was published in Health Affairs in February 2016, quantifying the “return on investment” from investments in immunization. The analysis covered 94 low and middle income countries, including all 73 Gavi countries. It uses projected coverage rates for … Continued